Correlation Between Rogers and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rogers and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rogers and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rogers and Spyre Therapeutics, you can compare the effects of market volatilities on Rogers and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rogers with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rogers and Spyre Therapeutics.
Diversification Opportunities for Rogers and Spyre Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Rogers and Spyre is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Rogers and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Rogers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rogers are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Rogers i.e., Rogers and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Rogers and Spyre Therapeutics
Considering the 90-day investment horizon Rogers is expected to under-perform the Spyre Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Rogers is 8.29 times less risky than Spyre Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Spyre Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,393 in Spyre Therapeutics on October 9, 2024 and sell it today you would earn a total of 1,049 from holding Spyre Therapeutics or generate 75.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rogers vs. Spyre Therapeutics
Performance |
| Timeline |
| Rogers |
| Spyre Therapeutics |
Rogers and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rogers and Spyre Therapeutics
The main advantage of trading using opposite Rogers and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rogers position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.The idea behind Rogers and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Spyre Therapeutics vs. Aldel Financial II | Spyre Therapeutics vs. Weibo Corp | Spyre Therapeutics vs. Space Communication | Spyre Therapeutics vs. Cheche Group Class |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |